Join our daily newsletter At The Bell to receive exclusive market insights
- Mental health technology company Medibio (MEB) appoints Thomas Young as its new Chief Executive Officer, effective from today
- Dr Young will be employed on a part-time basis, receiving a total remuneration of US$110,000 (A$163,900) per annum
- Medibio Non-Executive Director Dr Matt Mesnik says Dr Young’s background in mental health assessment is a tremendous asset to the company
- Medibio last traded at 0.2 cents at 3:06 pm AEST
Mental health technology company Medibio (MEB) has appointed Thomas Young as its new Chief Executive Officer, effective from today.
Dr Young is a family physician with more than 40 years of medical experience. He was the co-founder of Nview Behavioural Health and currently serves as its Chief Medical Officer and board member. Dr Young is also a medical director for Port of Hope, a non-profit substance use disorder clinic.
He previously served for six years as the Medical Director of Idaho Medicaid and for nine years as the Chief Clinical and Medical Officer of Idaho Medicare QIO Qualis Health.
Medibio Non-Executive Director Matt Mesnik said the company was excited to have Dr Young join its ranks as Chief Executive Officer.
“Tom has a tremendous background in healthcare as a provider, administrator, innovator and leader,” Dr Mesnik said.
“His background in mental health and mental health assessment is a tremendous asset toward the continued growth of the company.”
Dr Young will be employed on a part-time basis, receiving a total remuneration of US$110,000 (approximately A$163,983) per annum on the basis of 0.5 full-time equivalent hours.
Medibio last traded at 0.2 cents at 3:06 pm AEST.
